Healthcare

Eye diseases such as glaucoma, age-related macular degeneration, diabetic retinopathy, and macular edema require continuous monitoring of eye health, as they can be treated if detected early, but if left undetected, it can silently and rapidly progress to irreversible loss of vision. Home-based ophthalmic monitoring solutions can help in preventin...

05 Aug 2020  |  North America  |  Frost Radar

Frost Radar™: Medical Devices in Atrial Fibrillation Market, 2020

Benchmarking Future Growth Potential

Infographics

×

This Frost Radar™ analyzes emerging trends in the atrial fibrillation (AFib) landscape and profiles key market participants that deliver innovative solutions and maintain leadership in major segments in the care continuum, such as screening and monitoring, image-guided navigation and cardiac mapping, cardiac ablation, and left atrial appendage (L...

20 Jul 2020  |  North America  |  Frost Radar

Frost Radar™: US Healthcare Data Interoperability Market, 2020

Benchmarking Future Growth Potential

Infographics

×

Interoperability has become a critical consideration for all health IT (HIT) applications. All the major healthcare stakeholders across the world acknowledge the need to invest in digital infrastructure capabilities to facilitate cross-continuum patient information exchanges and support evidence-based care, at scale. Regulatory agencies are embraci...

The ICU is the most data-intensive part of the hospital, as continuous monitoring of patient health generates a huge volume of crucial data valuable for clinical decision making and future research. With digitalization, it is now easy and efficient to use analytics and connectivity solutions to analyze this data and draw insights for better care de...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

US-based providers lose an estimated $260 billion to $270 billion annually due to poor financial risk management and lack of infrastructure to support data-driven business decisions. For every dollar claimed, private and public payers on average offer a reimbursement of 86 cents to providers, resulting in a negative margin of 14% per dollar per pat...

The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...

Burden of Disease or Conditions Decision Support Database provides information on exhaustive list of Measurements on Incidence, Prevalence and Mortality for different types of Communicable and Non Communicable Disease.

Health Behaviors and Status Decision Support Database focuses on the habitual indicators, as well as on major transplants and surgeries performed across countries and occupational injuries involved in different sectors. Measurements in this DSD help to make a comparative study on the risk factors associated with different disease conditions across ...